Notch1 Identified as a Prognostic Factor for Glioma Patients

被引：8

作者：

Engh, Johnathan A.

机构：

来源：

NEUROSURGERY | 2011年 / 68卷 / 06期

关键词：

D O I：

10.1227/01.neu.0000398213.42865.91

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：N22 / N23

页数：2

共 5 条

[1]

Jang MS, 2000, CURR OPIN MOL THER, V2, P55

[2]

LI J, 2011, J SURG ONCOL 0116

[3] Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence [J].

Norden, A. D. ;

Young, G. S. ;

Setayesh, K. ;

Muzikansky, A. ;

Klufas, R. ;

Ross, G. L. ;

Ciampa, A. S. ;

Ebbeling, L. G. ;

Levy, B. ;

Drappatz, J. ;

Kesari, S. ;

Wen, P. Y. .

NEUROLOGY, 2008, 70 (10) :779-787

[4] Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation [J].

Purow, BW ;

Haque, RM ;

Noel, MW ;

Su, Q ;

Burdick, MJ ;

Lee, J ;

Sundaresan, T ;

Pastorino, S ;

Park, JK ;

Mikolaenko, I ;

Maric, D ;

Eberhart, CG ;

Fine, HA .

CANCER RESEARCH, 2005, 65 (06) :2353-2363

[5]

Sriuranpong V, 2001, CANCER RES, V61, P3200

← 1 →